Disclosure Of First-Time Adoption [Text Block]

Sopharma AD - Filing #6218824

Concept	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-01-01	As at 2021-01-01	As at 2021-01-01	As at 2021-01-01	As at 2021-01-01	As at 2021-01-01	As at 2021-01-01	As at 2021-01-01	As at 2021-01-01	As at 2021-01-01	As at 2021-01-01	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	—	50,284,000 BGN	66,201,000 BGN	444,634,000 BGN	36,788,000 BGN	—	—	12,512,000 BGN	—	—	658,868,000 BGN	1,644,000 BGN	—	—	646,975,000 BGN	11,893,000 BGN	—	682,000 BGN	134,798,000 BGN	—	—	—	2,685,000 BGN	134,798,000 BGN	566,595,000 BGN	360,770,000 BGN	2,282,000 BGN	- BGN	63,335,000 BGN	28,425,000 BGN	553,269,000 BGN	33,656,000 BGN	13,326,000 BGN	63,335,000 BGN	28,425,000 BGN	360,770,000 BGN	13,326,000 BGN	—	553,269,000 BGN	134,798,000 BGN	—	—	—	- BGN	33,656,000 BGN	2,685,000 BGN	—	—	—	—	566,595,000 BGN	—	—	2,282,000 BGN	—	34,142,000 BGN	2,873,000 BGN	134,798,000 BGN	360,656,000 BGN	575,772,000 BGN	- BGN	59,297,000 BGN	28,871,000 BGN	19,341,000 BGN	4,078,000 BGN	556,431,000 BGN
Comprehensive income	1,728,000 BGN	—	—	—	—	- BGN	- BGN	—	9,485,000 BGN	101,970,000 BGN	—	—	3,367,000 BGN	355,000 BGN	—	—	- BGN	—	—	- BGN	103,698,000 BGN	89,473,000 BGN	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	16,773,000 BGN	—	—	- BGN	29,614,000 BGN	637,000 BGN	—	—	—	- BGN	- BGN	37,000 BGN	- BGN	—	6,763,000 BGN	5,404,000 BGN	—	22,177,000 BGN	—	—	—	—	—	—	—	—	—	—	—
Profit (loss)	2,207,000 BGN	—	—	—	—	- BGN	- BGN	—	- BGN	89,496,000 BGN	—	—	- BGN	- BGN	—	—	- BGN	—	—	- BGN	91,703,000 BGN	89,496,000 BGN	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	25,280,000 BGN	—	—	- BGN	29,805,000 BGN	- BGN	—	—	—	—	- BGN	- BGN	- BGN	—	- BGN	4,525,000 BGN	—	29,805,000 BGN	—	—	—	—	—	—	—	—	—	—	—